ferentiate such tumors from choroid plexus carcinoma. 39 Neoplasms that originate in the ventricular wall and its lining are considered primary ventricular tumors, either with or without transependymal invasion, and those that arise in the adjacent cerebral structures but have a major (> two-thirds) exophytic component within the ventricle are considered secondary ventricular tumors with transependymal transgression (primary cerebral origin). 5 Cancer that is metastatic to the brain carries a poor prognosis, with a median survival time of 1 month without treatment. 4, 12 Similar to its role in the treatment of the more common intraparenchymal metastases, resection is an important component in the management of selected patients with intraventricular metastases. The overall goal of management is to "cure" the brain lesion(s) while avoiding significant morbidity to the patient. 38 A careful review of the literature revealed that studies of lateral-ventricle metastases are limited to case reports or rare examples in larger series of brain metastases. 38 We retrospectively report our experience of surgical management of these tumors in 29 patients with lateral-ventricle metastases who were treated at The University of Texas M. D. Anderson Cancer Center (M. D. Anderson). In these patients, our data illustrate the common clinical features encountered, surgical options, complications, and survival after resection.
Methods

Patient Population
In a search of the neurosurgical database at M. D. An derson, we identified 4364 patients with brain metastases who were surgically treated between June 1, 1993, and August 31, 2007 . Twenty-nine of these patients (0.7%) had metastases in the lateral ventricle. The study included patients with metastases to the choroid plexus as well as patients with metastases to the adjacent parenchyma in which more than two-thirds of the tumor mass was exophytic into the lateral ventricle. 5 
Tumor Management
All patients were diagnosed using brain MR imaging with Gd contrast enhancement, either for investigation of symptoms or for screening purposes, and were referred for neurosurgical consultation. All patients with known primary cancer underwent preoperative investigations to determine the extent of extracranial disease; however, this was done postoperatively if the lateral-ventricle metastasis was the first presentation. This testing routinely included a chest x-ray and CT scans of the chest, abdomen, and pelvis. One patient with preoperative evidence of LMD was included in the study, because the neurosurgeon decided to resect the tumor owing to progressive neurological deficit associated with increased tumor size, despite treatment by intrathecal chemotherapy and wholebrain irradiation. Patients were subgrouped according to the RPA classes established by the Radiation Therapy Oncology Group. 10 In this system, RPA Class I includes those with a KPS score ≥ 70 who are < 65 years old, with a controlled primary tumor and no extracranial metastases; RPA Class III includes those with a KPS score < 70; and RPA Class II includes all other patients.
All patients underwent craniotomy and tumor excision. Standard procedures were used for microneurosurgical tumor resection and for intraoperative frozen-section histopathological analysis. Tumors were resected either en bloc or piecemeal. Care was taken to pack off the ventricle with cottonoids to prevent spillage of tumor into the CSF. A definitive pathological diagnosis could only be confirmed postoperatively. All patients underwent postoperative brain MR or CT imaging with Gd contrast enhancement to determine the extent of tumor resection and to exclude the presence of hematoma or hydrocephalus.
Follow-Up Review
A follow-up review was performed postoperatively by the neurosurgeon by using CT and/or MR imaging of the brain. All patients were assigned KPS scores ~ 30 days after surgery, and these were compared with KPS scores obtained at the time of preoperative consultation.
Assessment of extracranial systemic disease was undertaken (as appropriate) by the neurosurgeons, medical oncologists, and radiation oncologists at M. D. Anderson. Surgical complications were defined as those occurring within 30 days after surgery. Complications were divided into 3 categories (neurological, regional, and systemic), with major and minor subclassifications that have been previously described. 33 Briefly, a complication was considered neurological if it directly produced a neurological deficit. Regional complications were those occurring within the cranium that were primarily related to the wound or the brain surface but did not directly result in a neurological deficit. Systemic complications were general medical conditions occurring at locations distant from the brain. Complications were regarded as major if they were life-threatening or required aggressive or invasive treatment, or if they prolonged the hospital stay. Operative mortality was defined as a death from any cause occurring within 30 days of the operation. The cause of death was deemed neurological if the systemic disease was stable, systemic if the neurological disease was stable, and combined if both systemic and neurological diseases were progressing.
To determine the local tumor recurrence rate, we compared postoperative MR images obtained in each patient with all images obtained subsequently. Local recurrence was defined as a tumor recurrence at the site of resection. If a new brain lesion occurred at a site within the brain that was distant from the resection site, it was recorded as a distant recurrence.
Statistical Methods
Frequencies and descriptive statistical analyses of demographic and clinical variables were obtained. The chisquare and Fisher exact tests were used for categorical variables, and the Student t-test and the Mann-Whitney test were used for continuous and ordinal variables, as appropriate. The Kaplan-Meier method was used to estimate postoperative survival time, and survival curves were compared using a log-rank test. Univariate and multivariate predictors of overall survival were assessed using the Cox proportional hazards model. The predictors investigated were as follows: age; sex; preoperative KPS score; the presence of pretreatment symptoms; histopathological features; the number of brain metastases; RPA classes; the interval between diagnosis of the primary tumor and diagnosis of the brain metastasis; the presence of extracranial metastases; the activity of the primary tumor at time of surgery; the surgical approach used; and the method of resection. Hazard ratios and their 95% CIs were computed. A p value of < 0.05 was considered significant. The Statistical Package for the Social Sciences (version 16.0) was used. Table 2 provides the frequency distribution of clinical and neuroimaging characteristics for 29 patients who had lateral-ventricle metastases. The study included 19 men and 10 women, with a mean age of 56 years (range 20-69 years). The preoperative KPS scores ranged from 60 to 100 (median 80). Twenty-four percent of patients were asymptomatic, whereas 76% had symptoms, with headache being evident in 31% of patients, motor deficit in 21%, unstable gait in 24%, memory deficit in 14%, speech deficit in 10%, visual deficit in 7%, and with very mild facial nerve palsy noted on neurological examination in 2 patients (7%). At the time of diagnosis, 83% of patients were fully conscious, whereas 17% had altered mental status.
Results
Clinical and Imaging Characteristics
The kidney was the site of primary cancer in 66% of patients. Other primary cancers originated in the lung and the skin (2 patients [7%] each), and in the endometrium, the breast, and the colon (1 patient [3%] each). However, the primary tumor could not be identified in 3 patients (10%). The interval between the diagnosis of the primary tumor and the diagnosis of brain metastasis ranged from 0 to 172 months, with a median of 24 months. There was no evidence of primary cancer at time of surgery in 16 patients (55%), but the activity of the primary tumor in the remaining 10 patients was described as stable in 3 (10%), progressive in 7 (24%), and these data were missing for 3 patients.
At the time of craniotomy, 20 patients (69%) had a single lateral-ventricle lesion, 2 (7%) had multiple lateralventricle metastases, and 7 (24%) had synchronous intraparenchymal metastases, 4 of whom underwent resection of both tumors in the same session.
The atrium was the site of metastasis in 66% of patients, perhaps owing to the presence of the large amount of choroid plexus within the trigone, and this site was followed by the body of the lateral ventricle in 21%, and then less frequently in the occipital horn, temporal, and frontal horns, with 3% of the metastases in each. More metastases occurred on the left side (55%) than on the right (45%).
Prior to resection, 4 patients (14%) had undergone treatment with WBRT, and 3 patients (10%) had undergone SRS. Resection was advised for these patients because of the progressive neurological deficit associated with increase in tumor size that occurred over 7 to 9 months of close clinical and radiological follow up.
Systemic metastases were present at the time of surgery in 16 patients (55%). These metastases were stable in 7 patients (24%) and progressing in 9 (31%). Based on RPA criteria, 27 patients (93%) were placed in Classes I and II, and 2 (7%) were placed in Class III.
Surgical Management
Resection was performed via the transcortical approach in 79% of patients and via the transcallosal approach in 21%. En bloc resection was performed in 13 patients (45%), whereas resection was piecemeal in 16 (55%). There was no bias toward either the en bloc or piecemeal method of resection during the period of the study; that is, neither method predominated, whether early or late in the study. Gross-total resection was achieved in 26 patients (90%), and subtotal resection was achieved in 3 (10%). Adjuvant WBRT was administered to 3 patients, including one of those who had undergone subtotal resection.
In descending order, the most common histological types of primary cancer were RCC (62%), melanoma (17%), adenocarcinoma (17%), and non-small cell lung carcinoma (3%). (Melanoma was the histopathological diagnosis for the 3 patients whose primary cancer was listed as unidentified.)
All patients were monitored until they died, with a median clinical follow-up interval of 6 months (range 0.5-127 months). Follow-up by brain MR imaging with Gd contrast enhancement was performed every 3 months, or earlier if the patient showed any neurological deterioration.
During follow-up, the cancer recurred locally (intraventricularly) in 6 patients (21%; including 2 who had undergone subtotal resection); distantly (intraparenchymally) in 1 patient (3%); and both locally and distantly in 3 patients (10%). One patient (3%) underwent a second operation for treatment of recurrent cerebral disease, whereas 4 (14%) underwent SRS, and 1 (3%) was treated with WBRT. Leptomeningeal disease occurred in 2 patients (7%), and was treated with chemotherapy.
Specifically, with respect to the 3 patients who had undergone subtotal resection, 1 showed no tumor recurrence, and 2 of them experienced local (intraventricular) recurrence, with one undergoing SRS and the other receiving no additional treatment.
Surgical complications are listed in Table 3 , with special attention being given to their status during the first 30 days after surgery. The overall complication rate was 52%. Complications were classified as neurological, regional, or systemic. Complications within each category were classified as major or minor, as mentioned earlier.
Patients experienced neurological complications within 30 days in 15 cases (52%), and in 11 (38%) of the 29 patients these were major complications. The 2 most common neurological complications were speech deficits (in 12 cases) and motor deficits (in 10).
Among patients with speech deficits (12 individuals), 5 experienced resolution of the deficit, 5 improved considerably (but slowly), and 2 showed no improvement.
Among patients with motor deficits (10 individuals), 1 experienced complete resolution of the deficit, and 6 improved considerably and were functionally independent in spite of noting mild weakness; however, the remaining 3 patients showed no improvement.
In 3 cases (10%), patients suffered regional complications, one of which was major. Seizures occurred in 3 patients and were controlled by antiseizure medications. One patient experienced a venous infarct after undergoing tumor resection via the transcallosal approach. This infarct may have resulted from cauterization of one of the draining veins. There were 3 cases (10%) of systemic complications, all of which were major. The median postoperative KPS score was 80. In 19 cases (66%), the postoperative KPS score was the same as it was preoperatively; the score was worse in 9 patients (31%); and it im- proved in 1 (3%). The surgery-related mortality rate was 7%. The cause of death in these 2 patients was systemic, with one dying of heart failure and fatal arrhythmias and the other of pneumonia.
Patient Survival
Among the 29 patients in our study, 5 (17%) were alive at the last follow-up visit. We excluded the patient with preoperative evidence of LMD from the survival statistics. The overall median survival time from the date of surgery for the remaining 28 patients was 11.7 months (95% CI 6.9-16.5 months). The Kaplan-Meier estimate of the cumulative survival rate at 2 years was 37%. When the survival pattern was reviewed after subgrouping patients according to their respective RPA classifications, the overall median survival time of the 8 RPA Class I patients was 11.4 months (95% CI 1.19-21.61 months), whereas the median survival time for the 18 RPA Class II patients was 12 months (95% CI 0.0-27.6 months), and that for the 2 RPA Class III patients was 3.3 months (95% CI not defined).
A univariate analysis (Table 4) was performed to determine which variables correlated with patient survival. The preoperative KPS score (Fig. 1) , number of brain lesions (1 or multiple), presence of histopathologically verified RCC (compared with other types) (Fig. 2) , and method of resection (piecemeal or en bloc) (Fig. 3) were all significant prognostic factors (p < 0.05) in the univariate determination. The presence of headache as a preoperative symptom, which occurred in some patients, had a nearly significant correlation with survival (p = 0.07), which may suggest that intracranial pressure was increased in those patients. Nevertheless, neither the presence of preoperative symptoms taken as a whole, nor individual variables such as patient age, RPA classification, involvement of the adjacent brain, the interval between diagnosis of the primary tumor and diagnosis of the brain metastasis, evidence of primary disease at the time of surgery, activity of the primary lesion at the time of surgery, type of surgical approach, or the presence of other systemic disease significantly affected survival. A multivariate analysis was performed to identify factors that could be used to ascertain which patients would benefit from this therapeutic approach. In the multivariate analysis, the preoperative KPS score, the presence of RCC as a histological type, and the method of resection correlated significantly with survival time (Table 4) . However, no other preoperative factors, including the number of brain lesions, demonstrated statistical significance.
Limitations of the Study
This study had multiple limitations. The small sample size may have resulted in insufficient statistical power to permit detection of significance for some variables, such as RPA class, involvement of the adjacent brain, the interval between diagnosis of the primary tumor and diagnosis of the brain metastasis, evidence of primary disease at the time of surgery, activity of the primary lesion at the time of surgery, type of surgical approach, or the presence of other systemic disease. The study was also limited to the selected group of patients who were treated by resection, without a control group with lateral-ventricle metastases treated by a different modality, such as WBRT or SRS. 
* More than 1 complication occurred per patient.
Discussion
Despite the rarity of metastasis to the lateral ventricle, it must be considered in the differential diagnosis of an intraventricular mass. Since Healy and Rosenkrantz 13 described a case of lateral-ventricle metastasis from lung carcinoma in 1980, 25 cases of lateral ventricle metastases have been reported in the literature (Table 1) . To our knowledge, this retrospective analysis of 29 patients who underwent craniotomy for lateral-ventricle metastases is the largest surgical series at a single institution to date.
The findings in this study concur with those in the previous case reports regarding the demographic data of patients with lateral-ventricle metastases, including the following: a male preponderance, the kidney as a source of primary cancer, RCC as a histopathological type, the trigone as a common location, lateral-ventricle metastasis possibly being the first presentation of cancer, a small number of patients with melanoma presenting with an occult primary site, and a variable interval between diagnosis of the primary disease and diagnosis of cerebral metastases.
The high frequency of intraventricular RCCs suggests that there may be a tropism of this tumor type for the ventricle, specifically for the choroid plexus, from which most of them arise. Matsumura and colleagues 24 pointed out that RCCs are divided into 2 types: the rapidly progressive one, which is fatal within a few years of diagnosis, and the slowly progressive type, in which patients survive for long periods with an indolent tumor. The long time between diagnosis of the brain metastasis and the initial diagnosis of RCC in the kidney that is common in the cases reported in the literature suggests that metastasis to the ventricle from RCC is more prevalent in the slowly progressive type. Taken together, these observations suggest that there may be a biological basis for the tendency of certain RCCs to metastasize to the ventricle. 38 Although surgery is a critical treatment modality for brain metastases, the surgeon must also consider the role of other options, particularly WBRT and SRS, when recommending the most appropriate treatment.
Patient selection is crucial in surgical decision making for patients with brain metastases. The clinician must weigh the immediate risk of surgical intervention against the long-term benefits of quality survival. 8, 38 Traditionally, patients selected as surgical candidates are expected to have good performance function (as assessed by a favorable KPS score), a single and surgically accessible metastasis, and stable or absent extracranial metastases.
In our study, the preoperative KPS score was a statistically significant predictor of survival in both univariate (p = 0.02) and multivariate analyses (p = 0.002). Although RPA class 10, 11, 23 did not reach statistical significance in this study as a prognostic variable, marked differences were noted in the median survival times of patients in RPA Classes I, II, and III (Table 4) .
Patients with single brain metastases are the most appropriate surgical candidates. Indeed, 2 independent prospective randomized studies demonstrated that resection followed by WBRT is superior to WBRT alone in the treatment of single brain metastases in terms of morbidity, recurrence, and overall survival. 28, 37 Although these studies did not specifically focus on intraventricular metastases, it is probably appropriate to conclude that resection of these metastases is likely to be superior to WBRT alone, as long as the lesion can be resected completely and with minimal morbidity.
Although the presence of > 1 brain metastasis has traditionally been considered a contraindication to surgery, more recently, resection has been used in the treatment of patients with "multiple" (that is, 2 to 4) brain metastases. 38 This approach is based on a retrospective study conducted at M. D. Anderson demonstrating that removal of multiple metastatic lesions was as effective as resection of a single metastasis, provided that all lesions were removed. 3 Our study demonstrated that the method of resection was a statistically significant predictor of survival, according to both univariate (p = 0.05) and multivariate analyses (p = 0.008). In 1996, Salvati and colleagues 32 mentioned that en bloc resection was among the favorable factors for preventing local recurrence in patients treated with resection for solitary cerebral metastasis from melanoma, presumably because this resection mode may prevent accidental dissemination of tumor cells. Indeed, the method of resection of brain metastases in relation to patient outcome will need more evaluation in the future.
The deep location of intraventricular metastases makes treatment with radiosurgery particularly attractive, especially for single lesions. In 2008, Muacevic and colleagues 26 reported the results of a phase III randomized controlled multiinstitutional trial in which microsurgery plus WBRT was compared with Gamma Knife SRS alone for treatment of single brain metastases. However, only patients with single untreated brain metastases ≤ 3 cm in maximum diameter (located at an operable site) were included in the study. The authors reported a 1-year local tumor control rate of 96.8% in patients treated with SRS compared with 82% in the microsurgery group. However, distant tumor control was significantly less frequently achieved in patients treated with SRS alone.
Conclusions
This is the first and largest series at a single institution that has focused exclusively on the surgical management of lateral-ventricle metastases. Our results indicate that patients who have RCC, a favorable preoperative KPS score, and a single ventricular metastasis that has been removed by en bloc resection have a better outcome than others.
